Complement inhibitor dosing regimens
US-2026069653-A1 · Mar 12, 2026 · US
Apellis Pharmaceuticals Inc holds 89 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 89 |
| Recent patents | 26 |
| First publication | Jun 4, 2015 |
| Latest publication | Mar 12, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026069653-A1 · Mar 12, 2026 · US
US-2026062448-A1 · Mar 5, 2026 · US
US-12528836-B2 · Jan 20, 2026 · US
US-12458695-B2 · Nov 4, 2025 · US
US-2025297287-A1 · Sep 25, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026069653-A1 · Mar 12, 2026 · US
US-2026062448-A1 · Mar 5, 2026 · US
US-12528836-B2 · Jan 20, 2026 · US
US-12458695-B2 · Nov 4, 2025 · US
US-2025297287-A1 · Sep 25, 2025 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 87 |
| Chemistry & Metallurgy | 77 |
| Physics | 28 |
Answers are generated from the same data shown on this page.